Full video transcriptClick to expand
Auto-generated transcript of @ace_of_spades_13's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00I'm Ace and this is my voice before taking testosterone.
- 0:05This is one month on Man Juice.
- 0:08Three months of becoming my Mormon family's worst nightmare.
- 0:13This is five months of only listening to Mother Mother.
- 0:16This is six months of injecting monster energy into my veins.
- 0:21This is nine months of smoking a pack a day until I sell my court husband.
- 0:26This is one year on testosterone.
One year on testosterone: what FTM timelines actually show
Quick answer
The video documents voice changes over one year of testosterone therapy in a transmasculine individual, consistent with androgen-induced laryngeal growth and lowering of fundamental frequency. Testosterone's virilizing effects on the voice are well-established in peer-reviewed literature and typically begin within the first three to six months of therapy. Individual variation in degree and rate of voice change is clinically significant and should be discussed during informed consent for gender-affirming hormone therapy.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For One year on testosterone: what FTM timelines actually show, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
One year on testosterone: what FTM timelines actually show is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "One year on testosterone: what FTM timelines actually show" from ๐โ ๏ธ ace โ ๏ธ๐. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video documents voice changes over one year of testosterone therapy in a transmasculine individual, consistent with androgen-induced laryngeal growth and lowering of fundamental frequency.
The reason this review is not generic is the source wording and the canonical claim label "trt 1 year on testosterone ftm trans transman lgbt genderaffirmi." In this clip, the useful excerpt is: "I'm Ace and this is my voice before taking testosterone." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The video documents voice changes over one year of testosterone therapy in a transmasculine individual, consistent with androgen-induced laryngeal growth and lowering of fundamental frequency.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video documents voice changes over one year of testosterone therapy in a transmasculine individual, consistent with androgen-induced laryngeal growth and lowering of fundamental frequency. Testosterone's virilizing effects on the voice are well-established in peer-reviewed literature and typically begin within the first three to six months of therapy. Individual variation in degree and rate of voice change is clinically significant and should be discussed during informed consent for gender-affirming hormone therapy.
- Testosterone lowers fundamental speaking frequency in transmasculine individuals, a finding replicated across multiple peer-reviewed studies including Ziegler et al. (2018, Journal of Voice).
- Most voice change occurs in the first 3 to 6 months of therapy, though changes can continue for up to 2 years according to Azul et al. (2017).
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Testosterone lowers fundamental speaking frequency in transmasculine individuals, a finding replicated across multiple peer-reviewed studies including Ziegler et al. (2018, Journal of Voice).
- Most voice change occurs in the first 3 to 6 months of therapy, though changes can continue for up to 2 years according to Azul et al. (2017).
- Voice deepening from testosterone is largely permanent and does not reverse if therapy is discontinued, per Hembree et al. (2017, JCEM Endocrine Society guidelines).
- Individual variation is significant. Genetics, androgen sensitivity, and dosing all influence outcomes, meaning one person's one-year results cannot be treated as a universal benchmark.
- Gender-affirming testosterone therapy is endorsed by WPATH, the Endocrine Society, and the American Academy of Pediatrics as safe and effective when medically supervised.
- This video contains no medical dosage claims or treatment recommendations. It is personal documentation of a lived experience, which is a lower-risk content category than instructional hormone advice.
Our take ยท Written by FormBlends editorial team ยท Reviewed by FormBlends Medical Team ยท This is not a transcript. It is our independent review of the video above.
What did @ace_of_spades_13 actually say?
Mostly, this video is a joke. Ace uses self-deprecating humor to mark one year on testosterone, attributing voice changes to things like "injecting monster energy" and "becoming my Mormon family's worst nightmare" rather than making direct medical claims. The actual factual content is minimal: Ace demonstrates a voice before starting testosterone and a noticeably deeper voice at the one-year mark. The phrase "Man Juice" is slang for testosterone. There are no dosage claims, no brand comparisons, and no promises about what testosterone will do for anyone else. This is a personal milestone video dressed up as comedy, not a medical tutorial. That matters for how we evaluate it.
The only real implicit claim here is that testosterone caused a significant voice change over one year. That claim, stripped of the Monster Energy jokes, is actually well-supported by research.
Does the science back this up?
Yes, the voice deepening is real and well-documented. Gender-affirming testosterone therapy in transmasculine individuals reliably produces voice lowering, and a year is a reasonable timeline to hear significant change.
Research backs this up clearly. Ziegler et al. (2018, Journal of Voice) found that fundamental frequency in transmasculine individuals decreased significantly within the first year of testosterone therapy, with most change occurring in the first three to six months. A separate study by Azul et al. (2017, International Journal of Language and Communication Disorders) noted that while testosterone produces voice lowering comparable to cisgender male puberty, individual variation is substantial. Some people hear dramatic change early; others wait longer. Van Borsel et al. (2008, Journal of Voice) confirmed that intramuscular testosterone consistently lowers speaking fundamental frequency in female-to-male transgender individuals. So the before-and-after voice difference Ace is demonstrating is not anecdote. It reflects a well-replicated physiological effect of androgens on the larynx.
What did they get wrong (or right)?
Ace got the core thing right: testosterone changes the voice, and a year is enough time to hear it. The humor framing means there is nothing technically wrong to debunk here. No false dosage claims, no miracle promises.
That said, a few things worth flagging for anyone watching this and forming expectations. First, Ace's experience is one data point. The Azul et al. (2017) review is explicit that voice outcomes vary considerably between individuals. Some transmasculine people do not achieve the degree of voice change they hoped for even after a year. Second, voice change on testosterone is largely permanent. That is generally framed as a positive in this community and for many it is, but it is a clinically relevant irreversibility that viewers should understand before starting therapy. Third, the video implies a clean, linear progression month by month. In practice, testosterone's effects are not always that tidy. Hembree et al. (2017, Journal of Clinical Endocrinology and Metabolism) notes that voice changes, like other virilizing effects, depend on dose, individual androgen sensitivity, and baseline hormone levels.
What should you actually know?
If you are considering testosterone therapy, this video is a reasonable slice of lived experience, not a clinical guide. Here is what the research actually tells us.
- Voice lowering is one of the most consistent and earliest physical effects of testosterone in transmasculine individuals, typically beginning within weeks to months of starting therapy.
- It is also one of the few effects that does not reverse if therapy is stopped, according to Hembree et al. (2017, JCEM), the Endocrine Society's clinical practice guidelines.
- Individual results vary. Genetics, baseline testosterone levels, and dosing all influence how much change occurs and how fast.
- Voice changes may continue beyond one year. Some research suggests ongoing changes up to two years into therapy.
- Gender-affirming hormone therapy in adults is considered safe and effective by major medical organizations including WPATH (World Professional Association for Transgender Health), the Endocrine Society, and the American Academy of Pediatrics, though it requires medical supervision and monitoring.
Ace's video is a celebration, not a prescription. Take it as the former and talk to a licensed provider about the latter.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
๐โ ๏ธ ace โ ๏ธ๐ ยท TikTok creator
142.1K views on this video
1 year on testosterone ๐ช๐ป๐จ๐ป #ftm #trans #transman #lgbt #genderaffirmingcare
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about testosterone lowers fundamental speaking frequency in transmasculine individuals, a finding?
Testosterone lowers fundamental speaking frequency in transmasculine individuals, a finding replicated across multiple peer-reviewed studies including Ziegler et al. (2018, Journal of Voice).
What does the video say about most voice change occurs in the first 3 to 6?
Most voice change occurs in the first 3 to 6 months of therapy, though changes can continue for up to 2 years according to Azul et al. (2017).
What does the video say about voice deepening from testosterone?
Voice deepening from testosterone is largely permanent and does not reverse if therapy is discontinued, per Hembree et al. (2017, JCEM Endocrine Society guidelines).
What does the video say about individual variation?
Individual variation is significant. Genetics, androgen sensitivity, and dosing all influence outcomes, meaning one person's one-year results cannot be treated as a universal benchmark.
What does the video say about gender-affirming testosterone therapy?
Gender-affirming testosterone therapy is endorsed by WPATH, the Endocrine Society, and the American Academy of Pediatrics as safe and effective when medically supervised.
What does the video say about this video contains no medical dosage claims?
This video contains no medical dosage claims or treatment recommendations. It is personal documentation of a lived experience, which is a lower-risk content category than instructional hormone advice.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by ๐โ ๏ธ ace โ ๏ธ๐, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.